Apros Therapeutics
PrivateLast Round
Series A
Aug 1, 2016
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Apros Therapeutics is a biotechnology company that develops tissue-targeted small molecule innate immune agonists for the treatment of cancer and infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Apros Therapeutics Comparables
Compare Apros Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Innovent Biologics | 66% | |
| Eikon Therapeutics | 57% | |
| Inimmune | 55% |
Apros Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Aug 1, 2016 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 691% MoM, from 162 to 1.3K.
Apros Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Apros Therapeutics's valuation, stock price, and market status.
Is Apros Therapeutics a public or private company?
Apros Therapeutics is a private company.
What is the current stock price of Apros Therapeutics?
Apros Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Apros Therapeutics worth (valuation)?
Valuation information for Apros Therapeutics is not publicly available.
Can I buy Apros Therapeutics stock?
Apros Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Apros Therapeutics's last funding round?
Apros Therapeutics's most recent funding round was Series A on August 1, 2016.
Who are the main investors in Apros Therapeutics?
Investor information for Apros Therapeutics is not publicly disclosed.
Will Apros Therapeutics IPO soon?
No public IPO plans have been announced for Apros Therapeutics.
How can I track Apros Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Apros Therapeutics's secondary market activity and sign up for updates.